User profiles for Gerardo Botti

Gerardo Botti

Direttore Dipartimento Anatomia Patologica, Istituto Nazionale Tumori Napoli
Verified email at istitutotumori.na.it
Cited by 27490

[HTML][HTML] Metabolic syndrome, endocrine disruptors and prostate cancer associations: biochemical and pathophysiological evidences

…, M Berretta, C D'Aniello, S Perdonà, P Muto, G Botti… - Oncotarget, 2017 - ncbi.nlm.nih.gov
This review summarizes the main pathophysiological basis of the relationship between
metabolic syndrome, endocrine disruptor exposure and prostate cancer that is the most common …

Human Urokinase Receptor Concentration in Malignant and Benign Breast Tumors by in Vitro Quantitative Autoradiography: Comparison with Urokinase Levels

…, MV Carriero, R Fonti, O Massa, PY Li, G Botti… - Cancer research, 1993 - AACR
We measured the tissue concentration of human urokinase receptor (uPAR) in 22 breast
carcinomas and 9 benign breast lesions using in vitro quantitative autoradiography. Tissue …

Towards the introduction of the 'Immunoscore'in the classification of malignant tumours

…, R Palmqvist, GV Masucci, G Botti… - The Journal of …, 2014 - Wiley Online Library
The American Joint Committee on Cancer/Union Internationale Contre le Cancer ( AJCC /
UICC ) TNM staging system provides the most reliable guidelines for the routine …

International validation of the consensus Immunoscore for the classification of colon cancer: a prognostic and accuracy study

…, P Dundr, H Skalova, K Nemejcova, G Botti… - The Lancet, 2018 - thelancet.com
Background The estimation of risk of recurrence for patients with colon carcinoma must be
improved. A robust immune score quantification is needed to introduce immune parameters …

[HTML][HTML] Cancer classification using the Immunoscore: a worldwide task force

…, A Lugli, I Zlobec, A Berger, C Bifulco, G Botti… - Journal of translational …, 2012 - Springer
Prediction of clinical outcome in cancer is usually achieved by histopathological evaluation
of tissue samples obtained during surgical resection of the primary tumor. Traditional tumor …

BRAF/NRAS mutation frequencies among primary tumors and metastases in patients with melanoma

…, A Manca, MC Sini, R Franco, G Botti… - Journal of Clinical …, 2012 - flore.unifi.it
The prevalence of BRAF, NRAS, and p16CDKN2A mutations during melanoma progression
remains inconclusive. We investigated the prevalence and distribution of mutations in these …

Expression of CXCR4 predicts poor prognosis in patients with malignant melanoma

…, P Giuliano, M Napolitano, R Franco, G Botti… - Clinical Cancer …, 2005 - AACR
Purpose: CXCR4 receptor and its unique ligand, the CXCL12 chemokine, have been recently
implicated in cancer metastasis. Evidence about the role of CXCR4/CXCL12 axis has …

[HTML][HTML] The SGLT-2 inhibitor empagliflozin improves myocardial strain, reduces cardiac fibrosis and pro-inflammatory cytokines in non-diabetic mice treated with …

…, L Altucci, M Conte, ML Canale, G Botti… - Cardiovascular …, 2021 - Springer
Background Empagliflozin (EMPA), a selective inhibitor of the sodium glucose co-transporter
2, reduced the risk of hospitalization for heart failure and cardiovascular death in type 2 …

Galectin-3-expression analysis in the surgical selection of follicular thyroid nodules with indeterminate fine-needle aspiration cytology: a prospective multicentre study

…, G Troncone, L Palombini, G Chiappetta, G Botti… - The lancet …, 2008 - thelancet.com
Background In the USA, about 30 200 well-differentiated thyroid carcinomas were diagnosed
in 2007, but the prevalence of thyroid nodules is much higher (about 5% of the adult …

Immunological and biological changes during ipilimumab treatment and their potential correlation with clinical response and survival in patients with advanced …

…, F Sandomenico, A Petrillo, G Botti… - Cancer immunology …, 2014 - Springer
Background Ipilimumab can induce durable disease control and long-term survival in patients
with metastatic melanoma. Identification of a biomarker that correlates with clinical benefit …